AUS
NZ
UK
CA
USA
IND
Healthcare
ImpediMed’s PREVENT Trial Gets An Entry Into Annual Meeting of The American Society Of Breast Surgeons
January 29, 2019 06:41 PM AEDT| By Team Kalkine MediaImpediMed shares bounced over 28% on the announcement of PREVENT trial being accepted for presentation at the 2019 Annual Meeting of the American Society of Breast Surgeons. In today?s announcement to ASX, Medical devices manufacturer, ImpediMed Lim...
Genetic Signatures’ Shares Surged On ASX Owing To Its Second-Quarter FY19 Activity Updates
January 29, 2019 05:15 PM AEDT| By Team Kalkine MediaGenetic Signatures Limited (ASX: GSS) is in Pharmaceuticals, Biotechnology, and Life Sciences industry. The company mainly operates as a molecular diagnostic company. On 29 January 2019, the company has reported its activities for the quarter ended...
SomnoMed Limited Reported Core Revenue Growth of 13% in Q2 FY19
January 29, 2019 03:09 PM AEDT| By Team Kalkine MediaHealthcare company, SomnoMed ?Limited (ASX: SOM) today (i.e., 29 January 2019) announced that its core revenues have increased by 13 percent in the Q2 FY 2019 as compared to the prior year, reaching $15.675 million for the three months period. In th...
Race Oncology Releases Its December Quarter Result Update
January 29, 2019 08:30 AM AEDT| By Team Kalkine MediaOn 25 January 2019, Race Oncology Ltd (ASX: RAC), a pharmaceutical company, has announced its Consolidated Quarterly statement of cash flows. As at 31 December 2018, the Company?s cash balance was AUD 2,079,000, representing a decrease from the cash...
OCA Announces Decent 1HY2019 Results
January 28, 2019 06:07 PM AEDT| By Team Kalkine MediaOceania Healthcare Limited (ASX: OCA) announces its half-yearly results to the market (6 months to 30 November 2018). The underlying NPAT was 5.3% above 1HY2018 and there is 8.7% growth in continuing operations as compared to 1HY2018. OCA is a care f...
Althea Group Announces Achievement Of 300 Patients: What Market Players Need To Know
January 25, 2019 09:30 PM AEDT| By Team Kalkine MediaAlthea Group Holdings (ASX: AGH) had come forward and made an announcement about the patients which were prescribed its medicinal cannabis with the help of the press release. Althea Group Holdings happens to be the licensed producer as well as import...
The Share Price Of Factor Therapeutics Remains Unaffected By The Retirement Of The Chief Executive Officer
January 25, 2019 09:17 PM AEDT| By Team Kalkine MediaBiotechnology Company, Factor Therapeutics Limited (ASX: FTT) today made an announcement regarding a change in the Company's management. In the announcement, the company has informed that Dr. Rosalind Wilson has completed her tenure as Chief Executiv...
Why ResMed's Stock Nosedived Today?
January 25, 2019 06:51 PM AEDT| By Team Kalkine MediaOn 25 January 2019, ResMed Inc. (NYSE: RMD, ASX: RMD) announced its December quarter financial and business results. ResMed is a leading player under Australia?s health care sector, engaged in offering innovative cloud-connected medical devices trans...
AusCann Group Announced Research & Development Facility Acquisition
January 25, 2019 06:00 PM AEDT| By Team Kalkine MediaAusCann Group Holdings Limited (ASX: AC8) had made an announcement of the acquisition of Research and Development Facility with the help of press release. As per the press release dated January 25, 2019, the company stated that they have wrapped up t...
Alcidion Group Announces Key Changes In Its Board And Senior Management
January 25, 2019 04:14 PM AEDT| By Team Kalkine MediaOn 25 January 2019, Alcidion Group Limited (ASX: ALC) has announced changes in its Board and senior management, as the company begins its next stage of growth following the successful integration of MKM Health and Patientrack into the Alcidion Group...
Botanix Pharmaceuticals Moves Up On ASX On Completion of Investigator’s Meeting for BTX 1204 Phase 2 Atopic Dermatitis Clinical Study
January 25, 2019 02:44 PM AEDT| By Team Kalkine MediaOn 25 January 2019, biopharmaceutical dermatology company, Botanix Pharmaceuticals Limited (ASX: BOT) announced that it had completed its Investigator?s Meeting for the BTX 1204 Phase 2 atopic dermatitis clinical study with investigating dermatologis...
50% Crash In The Price Of Creso Pharma In 1 Year
January 25, 2019 02:08 PM AEDT| By Team Kalkine MediaMedical Cannabis Company, Creso Pharma Limited?s (ASX: CPH) shares have lost almost half their value in the last one year. Despite being a part of the booming cannabis industry, this pot stock?s share prices have declined by approximately 50 percent...
EMvision Announced Positive Safety Observations From Healthy Human Trials
January 24, 2019 07:20 PM AEDT| By Team Kalkine MediaMedical device company, EMvision Medical devices Ltd (ASX: EMV) made an announcement today (24 January 2019) in which the company disclosed positive safety observations from healthy human trials conducted at the University of Queensland. Following th...
Why Did Proteomics International Plunge By Over 11% On ASX?
January 24, 2019 06:06 PM AEDT| By Team Kalkine MediaOn 24 January 2019, a medical technology company, Proteomics International Laboratories Limited (ASX: PIQ), announced that it had withdrawn its exclusive licensing deal with medical diagnostics company, PrismHealthDx due to continuing rollout postpon...
ImExHS Limited Signs New Distribution Agreement in Panama
January 24, 2019 05:12 PM AEDT| By Team Kalkine MediaThe company announces that it has recently signed a new non-exclusive distribution agreement, with a leading medical and security technology company in Panama known as ATX Panama SA (ATX). This agreement now offers a great opportunity to expand its p...
Creso Pharma Limited Raised $3 Million In Institutional Placement
January 24, 2019 02:09 PM AEDT| By Team Kalkine MediaCreso Pharma Limited (ASX: CPH) develops and commercializes innovative and high-quality cannabis product. The company made an announcement today (24 January 2019) stating that it has successfully raised $3 million in Institutional Placement. Earlier...
The Share Price of RGS Zoomed Up By 6.061% Post The Appointment Of The New CEO
January 24, 2019 01:39 PM AEDT| By Team Kalkine MediaRegeneus Limited (ASX: RGS), a healthcare company which deals with regenerative medicine announced the appointment of Mr. Leo Lee as their new Chief Executive officer and member of the board with immediate effect. He will be replacing the outgoing CE...
IHL Enters Exclusive Supply Agreement with Corporate Dentist 1300 Smiles
January 23, 2019 11:50 PM AEDT| By Team Kalkine MediaOn 23 January 2019, Impression Healthcare Limited (ASX: IHL) signed an exclusive supply agreement with 1300 SMILES Limited (ASX: ONT), a leading dental group with a strong presence in Queensland. As per the agreement, from February, all the custom-f...
AdAlta Releases Its December Quarter Business Report
January 23, 2019 01:35 PM AEDT| By Team Kalkine MediaOn 22 January 2019, AdAlta Limited (ASX:1AD) has released a manufacturing update for AD-214. Based on current timelines, manufacturing remains on track which will move AdAlta?s lead program for the treatment of Idiopathic Pulmonary Fibrosis (IPF) int...
Race Oncology On-Boards Professor Borje Andersson To Support Bisantrene Initiatives
January 22, 2019 09:04 PM AEDT| By Team Kalkine MediaOn 22 January 2019, Race Oncology Limited (ASX: RAC) announced that it had signed a consulting agreement with Professor Borje Andersson from the M.D. Anderson Cancer Research Centre in Texas, for an initial period of 12 months. Race Oncology is an A...
Advertise your brand on Kalkine Media